High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer
2020 · Aging · 32 citations
https://doi.org/10.18632/aging.102718
Y
Yichang Hao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
269
Citations
8
h-index
8
i10-index
Yichang Hao is an academic researcher from Peking University. The author has contributed to research in topics: Renal cell carcinoma treatment & Urinary Bladder and Prostate Research & Cancer, Lipids, and Metabolism. The author has an h-index of 8, co-authored 42 publications.
Papers by this author
worksAlendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension
2015 · Osteoporosis International · 23 citations
https://doi.org/10.1007/s00198-015-3141-y
Efficacy and safety of systemic treatment for progressive and refractory desmoid tumor: a systematic review and Bayesian network meta-analysis
2024 · Discover Oncology · 4 citations
https://doi.org/10.1007/s12672-024-01494-z
Deficient DNA mismatch repair and Nectin-4 expression in upper tract urothelial carcinoma (UTUC)
2025 · Journal of Cancer Research and Clinical Oncology · 1 citations
https://doi.org/10.1007/s00432-025-06312-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat